Hidden in Plain Sight: Time Displacement and Format Obfuscation in VAERS
VAERS Time Displacement and Reformatting Explained
This is projected to be the first in a series of illustrative case reports of what may be recognized someday as unique disease clusters that will provisional be termed Turbo CoVax Disease: Rapid Onset Progressive Multiple Organ-Adult variety. (TCD ROMOS-A)
Time Displacement and Format Obfuscation are found in Adverse Event Reports siloed in US government databases but that effectively hide the information contained in the reports. In the process of sorting through VAERS cases examples of these techniques were identified (#1512205 and #1277549). They both proved to be quite interesting.
The COVID19 gene therapy product developed and promoted by Janssen and Johnson and Johnson was withdrawn from the market because of six reports of cerebral vein thrombosis. A seventh cases was discovered in the reports filed under COVID19 injection date of 2001.
A more or less randomly selected case, VAERS #1512205, from the 93 cases in VAERS with the injection date of 2001 proved to be an important find. It turned out to be a case of a 39-year old male who developed cerebral vein thrombosis after he was injected with Janssen/JNJ’s COVID19 gene therapy product, a product taken off the market about the time he was injected. This was a bad choice of a case to lose track of.
While investigating cases of abnormal free light chains VAERS case #1277549 was identified because of elevated kappa light chains and an abnormal kappa lambda ratio. This profile of elevated kappa and kappa/lambda ratio is indicative of a number of conditions including but not limited to autoimmunity, inflammation and bone cancer such as multiple myeloma and plasmacytoma.
VAERS Case #1277549, a previously healthy 20 year old male, experienced rapid onset of multiple organ failures within hours of receiving BNT162b2. Within two weeks he was on dialysis for kidney failure, he had microinfarctions in two or possibly three separate regions of his brain, he lost his hearing, had immunological test results indicating immune suppression while simultaneously showing signs of abnormal lymphocyte activity associated with kidney disease and lymphoid malignancies. Additionally there was evidence of internal bleeding, pulmonary effusion, vertebral artery aneurysm and possible myopericarditis.
I took this photograph at https://vigeland.museum.no/en/collection/s%C3%B8k-i-samlingen in Oslo, Norway. The museum is set in a large garden with the sculptor's work on display throughout. There was no explanation but yours fits well. If you visit Oslo Vigelund is a must along with https://www.visitoslo.com/en/product/?TLp=181474, the Resistance Museum at the harbor.
The JNJ recall is odd given they only admitted to six cases of CVT while with BNT162b2 there were over 1200 fatalities reported in Pfizer document 5.3.6 after 8/10 weeks (US/UK) and over 40,000 subjects reporting adverse events.
Pic from Gates of Hell? It is unpredictable which adverse effects will develop with the RNA injection that reprograms cellular function. J&J got out early because they recognized the great harm being created and they already had more than their share of lawsuits! My view .